TY - JOUR
T1 - Digital and precision clinical trials
T2 - innovations for testing mental health medications, devices, and psychosocial treatments
AU - Lenze, Eric
AU - Torous, John
AU - Arean, Patricia
N1 - Publisher Copyright:
© 2023, The Author(s), under exclusive licence to American College of Neuropsychopharmacology.
PY - 2024/1
Y1 - 2024/1
N2 - Mental health treatment advances - including neuropsychiatric medications and devices, psychotherapies, and cognitive treatments - lag behind other fields of clinical medicine such as cardiovascular care. One reason for this gap is the traditional techniques used in mental health clinical trials, which slow the pace of progress, produce inequities in care, and undermine precision medicine goals. Newer techniques and methodologies, which we term digital and precision trials, offer solutions. These techniques consist of (1) decentralized (i.e., fully-remote) trials which improve the speed and quality of clinical trials and increase equity of access to research, (2) precision measurement which improves success rate and is essential for precision medicine, and (3) digital interventions, which offer increased reach of, and equity of access to, evidence-based treatments. These techniques and their rationales are described in detail, along with challenges and solutions for their utilization. We conclude with a vignette of a depression clinical trial using these techniques.
AB - Mental health treatment advances - including neuropsychiatric medications and devices, psychotherapies, and cognitive treatments - lag behind other fields of clinical medicine such as cardiovascular care. One reason for this gap is the traditional techniques used in mental health clinical trials, which slow the pace of progress, produce inequities in care, and undermine precision medicine goals. Newer techniques and methodologies, which we term digital and precision trials, offer solutions. These techniques consist of (1) decentralized (i.e., fully-remote) trials which improve the speed and quality of clinical trials and increase equity of access to research, (2) precision measurement which improves success rate and is essential for precision medicine, and (3) digital interventions, which offer increased reach of, and equity of access to, evidence-based treatments. These techniques and their rationales are described in detail, along with challenges and solutions for their utilization. We conclude with a vignette of a depression clinical trial using these techniques.
UR - http://www.scopus.com/inward/record.url?scp=85166983949&partnerID=8YFLogxK
U2 - 10.1038/s41386-023-01664-7
DO - 10.1038/s41386-023-01664-7
M3 - Review article
C2 - 37550438
AN - SCOPUS:85166983949
SN - 0893-133X
VL - 49
SP - 205
EP - 214
JO - Neuropsychopharmacology
JF - Neuropsychopharmacology
IS - 1
ER -